Technical Analysis for APLT - Applied Therapeutics, Inc.

Grade Last Price % Change Price Change
A 9.09 2.83% 0.25
APLT closed up 2.83 percent on Friday, November 1, 2024, on 80 percent of normal volume.
Earnings due: Nov 7
*** please verify all earnings dates ***
3 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up

Date Alert Name Type % Chg
Pocket Pivot Bullish Swing Setup 0.00%
20 DMA Support Bullish 2.83%
Pocket Pivot Bullish Swing Setup 0.66%
Up 3 Days in a Row Strength 0.66%
20 DMA Support Bullish 3.89%
Crossed Above 20 DMA Bullish 5.33%
Fell Below 20 DMA Bearish 7.83%
20 DMA Support Bullish 1.34%
180 Bullish Setup Bullish Swing Setup 1.34%
Outside Day Range Expansion 4.24%

   Recent Intraday Alerts

Alert Time
Possible Pocket Pivot about 18 hours ago
Down 1% about 23 hours ago
10 DMA Support about 24 hours ago
Rose Above Previous Day's High about 24 hours ago
Up 3% about 24 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Applied Therapeutics, Inc., a biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-001 that is in phase II clinical trials for treating diabetic cardiomyopathy, as well as is in phase I clinical trials to treat diabetic peripheral neuropathy. The company’s preclinical stage products include AT-001 for acute myocardial infraction; AT-007 for treating galactosemia; AT-003 to treat diabetic retinopathy; and AT-104 for the treatment of orphan hematological oncology. Applied Therapeutics, Inc. was founded in 2016 and is headquartered in New York, New York.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Organ Systems Diabetes Cardiovascular Disease Diabetes Mellitus Diabetic Retinopathy Cardiomyopathy Myopathy Preclinical Stage Product Retinopathy Peripheral Neuropathy Stage Products Diabetic Peripheral Neuropathy Lactose Novel Products Preclinical Stage Products

Is APLT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 9.39
52 Week Low 1.79
Average Volume 2,899,182
200-Day Moving Average 5.61
50-Day Moving Average 7.48
20-Day Moving Average 8.68
10-Day Moving Average 8.84
Average True Range 0.58
RSI (14) 61.24
ADX 31.91
+DI 23.48
-DI 13.37
Chandelier Exit (Long, 3 ATRs) 7.58
Chandelier Exit (Short, 3 ATRs) 9.31
Upper Bollinger Bands 9.41
Lower Bollinger Band 7.96
Percent B (%b) 0.78
BandWidth 16.73
MACD Line 0.37
MACD Signal Line 0.44
MACD Histogram -0.0611
Fundamentals Value
Market Cap 702.01 Million
Num Shares 77.2 Million
EPS -1.25
Price-to-Earnings (P/E) Ratio -7.27
Price-to-Sales 20.14
Price-to-Book 4.89
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.89
Resistance 3 (R3) 9.86 9.57 9.75
Resistance 2 (R2) 9.57 9.37 9.58 9.71
Resistance 1 (R1) 9.33 9.24 9.45 9.36 9.66
Pivot Point 9.04 9.04 9.10 9.05 9.04
Support 1 (S1) 8.80 8.84 8.92 8.83 8.52
Support 2 (S2) 8.51 8.71 8.52 8.47
Support 3 (S3) 8.27 8.51 8.43
Support 4 (S4) 8.30